nov-205
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2006 (NCT00372983)
Timeline
Indications
Studied for
Mechanism of action
- Hepatitis C virusINHIBITOR
Hepatitis C virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nov-205
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01058512 | Phase 2 | Mar 1, 2010 | Cellectar, Inc |
| NCT00372983 | Phase 1 | Aug 1, 2006 | Cellectar, Inc, University of Massachusetts |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cellectar, Inc | For profit | 2 | 2 | 2 | 2006 |
| University of Massachusetts | Academic/Hospital | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1